Back to search

National and Kapodistrian University of Athens

Συσχέτιση CRH και προγεστερόνης στον πρόωρο τοκετό και μεταβολές μετά από την χορήγηση RU 486 και μεθοτρεξάτης

Abstract

dc:description

1. ABNORMAL PROGESTERONE AND CORTICOTROPIN RELEASING HORMONE LEVELS ARE ASSOCIATED WITH PRETERM LABOUR Objective: This study examined whether maternal plasma progesterone and Corticotropin Releasing Hormone (CRH) concentrations can predict the likelihood of preterm labour. Study Design: Maternal plasma progesterone and CRH concentrations were examined in a total of 51 women. The subject cohort included 20 women who were followed from the beginning of the third trimester (28 to 34 weeks gestation), half of whom delivered early preterm and half of whom were not in labour and subsequently delivered at full term (N=10 per group). In a follow-up experiment, 31 women who were admitted during labour for delivery were examined, 15 of whom delivered preterm and 16 of whom delivered at full term. Comparisons between women who delivered preterm and those that delivered at full term were made by t-tests. Results: Mean progesterone concentration was approximately 30% lower at 28 to 34 weeks gestation in women who delivered prematurely than in women who delivered at term (p<0.001). Meanwhile mean CRH concentration was 6-fold higher at 28 to 34 weeks gestation in women who experienced spontaneous preterm labour than in those who went into labour at term (p<0.001). Preterm mothers had lower progesterone (p<0.05) and CRH (p<0.01) levels during active labour than full term mothers. Progesterone levels normalised within 24 hours of delivery in preterm mothers, while CRH levels remained slightly elevated (p<0.01). Conclusions: Maternal progesterone and CRH measurements taken early in the third trimester may be of use as biochemical markers of pregnancies at high risk of premature labour. 2. CHANGES IN CORTICOTROPIN RELEASING HORMONE AND PROGESTERONE ASSOCIATED WITH ONSET AND PROGRESSION OF LABOR Aim: To examine the relationship between maternal plasma progesterone and Corticotrophin Releasing Hormone (CRH) levels and the progression of labor. Methods: Mean plasma concentrations of CRH and progesterone were measured during latent labor, during active labor and 24 h postpartum in 9 mothers who delivered vaginally at full term. Progesterone levels during the latent phase of labor in these women were also compared with progesterone levels in women who were scheduled to deliver by cesarean section at full term before the onset of labor. Results: Maternal plasma progesterone levels were 18% higher in the active phase than in the latent phase of labor (p<.01) and then declined significantly by 24 h postpartum (p<0.001). Maternal plasma CRH levels were 24% higher in the active phase than in the latent phase of labor (p<0.01), and then declined significantly by 24 h postpartum (p<0.001). Maternal plasma progesterone levels were 19% higher in women at full term who were not in labor than in women in latent labor (p<.1). Conclusions: Progesterone levels are reduced in full term women who have begun labor relative to full term women who have not. Following this dip, progesterone and CRH levels increase as labor progresses and then decrease precipitously in the immediate postpartum period. Elucidating the hormonal mechanisms regulating parturition will be necessary to control preterm labor. 3. CHANGES IN CORTICOTROPIN RELEASING HORMONE AND PROGESTERONE ASSOCIATED WITH MIFEPRISTONE AND METHOTREXATE Aim: To examine the relationship between maternal plasma progesterone and corticotrophin releasing hormone (CRH) levels and the medications mifepristone and methotrexate. Methods: Mean plasma concentrations of CRH and progesterone were measured in five women who had an abortion (at 8wks) before the abortion and 24 hours after receiving 200 mgr RU-486. Mean plasma concentrations of CRH and progesterone were also measured in four women who had ectopic pregnancy: before and after receiving 50 mgr/m2 methotrexate. Comparisons were made by t-tests. Results: Plasma progesterone levels were 25% lower (p<0.05) and plasma CRH levels were 50% lower after receiving 200mgr RU-486 (p<0.01). In Experiment 2 there is no a statistical significant difference found in plasma progesterone and CRH levels in women receiving methotrexate as a treatment for ectopic pregnancy.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2010

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Stamatelou, F
  • Σταματέλου, Φωτεινή

Subjects

dc:subject × 9

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/27321

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Stamatelou, F; Σταματέλου, Φωτεινή. Συσχέτιση CRH και προγεστερόνης στον πρόωρο τοκετό και μεταβολές μετά από την χορήγηση RU 486 και μεθοτρεξάτης. National and Kapodistrian University of Athens, 2010. http://hdl.handle.net/10442/hedi/27321